MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Subdomain-specific cognitive decline and its effect on caregiver burden in Mexican population living with Parkinson’s Disease.

    G. Martin-Mafud, A. Hernández-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, M. Velasco-Delgado (Mexico City, Mexico)

    Objective: To determine whether different subdomains of the MoCA associate with caregiver burden. Background: Caregivers improve the quality of life for Parkinson's patients (PwP), despite…
  • 2025 International Congress

    The MJFF PRKN/PINK1 Project

    E-J. Vollstedt, A. Balck, AN. Basak, M. Brand, N. Brüggemann, J-C. Corvol, S. Ertan, M. Funayama, M. Gagliardi, N. Hattori, C-H. Lin, K. Lohmann, P. Mir, D. Narendra, G. Saranza, L. Stefanis, A-H. Tan, EM. Valente, S. Padmanabhan, K. Brockmann, C. Klein (Luebeck, Germany)

    Objective: To i) establish an expert consortium on PRKN/PINK1-linked Parkinson’s disease (PD), ii) improve our understanding of genotype-phenotype relationships and disease mechanisms, and iii) establish…
  • 2025 International Congress

    Freezing of Gait Detection and Warning System for Parkinson’s Patients

    D. Kusbeci, T. Ozkarslioglu, N. Durmaz Celik, Z. Saatci (Izmir, Turkey)

    Objective: This study aims to mitigate the adverse effects of FOG through a novel, wearable device designed for real-time detection and intervention. Background: One of…
  • 2025 International Congress

    An Exercise Prescription to Slow the Progression of Parkinson’s Disease

    J. Alberts, A. Rosenfeldt, C. Lopez-Lennon, E. Jansen, C. Felix, E. Zimmerman, P. Imrey, H. Fernandez, K. Mckee, L. Dibble (Cleveland, USA)

    Objective: To evaluate the efficacy of a 12-month, home-based, high-intensity aerobic exercise intervention in slowing the progression of Parkinson’s disease (PD) using rate-focused cycling. Background:…
  • 2025 International Congress

    Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON study: Effect of Levodopa Dose

    J. Ferreira, O. Rascol, F. Stocchi, A. Antonini, H. Brigas, J. Moreira, JF. Rocha, M. Fonseca, D. Ramos, J. Holenz, W. Poewe (Lisbon, Portugal)

    Objective: This post-hoc analysis of the EPSILON study evaluated whether levodopa dose (<400mg/day vs. ≥400mg/day) and opicapone (OPC) timing (at double-blind [DB] or open-label extension…
  • 2025 International Congress

    Evaluation of Impact of Helicobacter Pylori Eradication on Symptomatology and Quality of Life in Parkinson’s Disease

    A. Kakkar, G. Vishwas, S. Mehta, S. Pattanaik, S. Bhattacharyya, V. Sharma, M. Modi (Chandigarh, India)

    Objective: This study aimed to determine the effects of Helicobacter Pylori(HP) eradication treatment on motor and non-motor symptoms and quality of life of PD patients…
  • 2025 International Congress

    The NICE-PD Trial: Cost-Effectiveness of Specialized Nursing Interventions for People with Parkinson’s Disease

    D. Radder, B. Maas, E. Zeeboer, H. Lennaerts, L. Ter Brake, E. Adang, J. Int Hout, H. Vermeulen, T. van Asseldonk, C. Delnooz, R. Hagen, M. Munneke, B. Bloem, N. de Vries (Nijmegen, Netherlands)

    Objective: We aimed to assess the cost-effectiveness of adding specialized nursing care to usual care compared with usual care alone in people with Parkinson’s disease…
  • 2025 International Congress

    Who is lost? Monitoring recruitment in the EJS ACT-PD trial to improve understanding of inclusive recruitment

    M-L. Zeissler, R. Davidson, K. Hockey, G. Mills, R. Petty, C. Pugh, T. Liddle, Y. Yiannakou, T. Foltynie, C. Carroll (Newcastle upon Tyne, United Kingdom)

    Objective: To improve equitable access to participation in the EJS ACT-PD trial (Edmond J Safra Accelerating Clinical Trials in Parkinson’s Disease) Background: A minority of…
  • 2025 International Congress

    A Systematic Site Selection Approach to Ensure Efficient and Diverse Participant Recruitment to a Large-Scale Multi-Arm, Multi-Stage Platform Trial for Parkinson’s

    G. Mills, M-L. Zeissler, O. Bandmann, R. Barker, J. Carpenter, S. Collins, J. Duffen, S. Gandhi, L. Houlden, C. Gonzalez-Robles, C. Mcalpine, K. Mcfarthing, C. Pugh, A. Schapira, A. Schrag, C. Shakeshaft, T. Foltynie, C. Carroll (London, United Kingdom)

    Objective: To select up to 40 delivery sites to successfully recruit and retain a participant population representative of people with Parkinson’s disease (PwP) in the…
  • 2025 International Congress

    PADOVA: Topline results from a Phase IIb study of prasinezumab in early-stage Parkinson’s disease participants on stable symptomatic treatment

    T. Nikolcheva, G. Pagano, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, N. Pross, A. Monnet, G. Respondek, L. Rutten-Jacobs, V. Schlegel, L. Boak, G. Kerchner, P. Brundin, H. Svoboda, A. Bonni (Basel, Switzerland)

    Objective: To evaluate the effect of prasinezumab on slowing down disease progression in participants with early-stage Parkinson’s disease (PD) on stable symptomatic medication. Background: Prasinezumab…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley